Early Day Motion·EDM 182

MEDICINE ADVERTISEMENTS

25 November 200445 Signatures

Motion Text

That this House is concerned that misleading advertisements for medicines can confuse prescribers, patients and consumers leading to the unnecessary or inappropriate use of these products posing a potential danger to public health; calls for more effective regulation of advertising of pharmaceutical products; and believes this function should be removed from the Medicines and Healthcare Products Regulatory Agency and transferred to a new, independent regulator funded by a levy on the industry and that this body should adopt a robust approach to curb misleading campaigns and to take effective action when this occurs.